1 Tirzepatide 15 mg: -11.2 kg average weight loss Injectable semaglutide 1 mg: -5.7 kg average weight loss HbA1c: -2.30% with tirzepatide 15 mg vs -1.86% with semaglutide 1 mg Rybelsus 14 mg (the highest available oral dose) produces roughly equivalent blood levels to injectable semaglutide 0.5-1.0 mg per week, which is at or below the injectable dose tested in SURPASS-2
When you stop semaglutide, appetite-suppressing hormone effects reverse within days to weeks, and hunger typically returns to pre-treatment levels
Immediate medical attention is required if patients experience severe abdominal pain, particularly if localized, persistent, or accompanied by fever, which may indicate complications such as bowel obstruction, fecal impaction, or rarely, intestinal ischemia
Each pen delivers exactly one dose
Growth hormone secretagogues like ipamorelin and sermorelin indirectly support fat loss through enhanced growth hormone production